Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 21 Oct 2026 for Disc Medicine, Inc., €975k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
Atlas Venture Opportunity Fund I, LP: trading record in brief
This profile gathers the share dealings of Atlas Venture Opportunity Fund I, LP across 3 companies, led by Dyne Therapeutics, Inc., Kymera Therapeutics, Inc. and Disc Medicine, Inc. In total, 22 filings cover trades dated from 17 June 2026 to 21 October 2026.
The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Most recently, on 21 October 2026, the filings show a transaction worth €975k in Disc Medicine, Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Atlas Venture Opportunity Fund I, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations22 total
13,783 shares@ US$79.48Common StockSEC144:0001628280-26-066748
2,869 shares@ US$78.930.0075% mcap26.6% of flowCommon StockSEC144:0001628280-26-066536
5,937 shares@ US$56.840.011% mcap54.0% of flowCommon StockSEC144:0001628280-26-066326
912 shares@ US$79.370.0028% mcap24.3% of flowCommon StockSEC144:0001628280-26-060746
2,810 shares@ US$80.050.0087% mcap75.7% of flowCommon StockSEC144:0001628280-26-060504
322,465 shares@ US$25.960.27% mcap48.8% of flowCommonSEC144:0001628280-26-057191
63,643 shares@ US$26.170.053% mcap9.7% of flowCommonSEC144:0001628280-26-056842
60,858 shares@ US$22.840.045% mcap8.2% of flowCommonSEC144:0001628280-26-047534
100,019 shares@ US$23.070.074% mcap13.6% of flowCommonSEC144:0001628280-26-047358
40,702 shares@ US$20.940.028% mcap5.0% of flowCommonSEC144:0001628280-26-046093
10,473 shares@ US$108.120.012% mcap5.2% of flowCommon StockSEC144:0001628280-26-046098
64,411 shares@ US$20.610.027% mcap7.9% of flowCommonSEC144:0001628280-26-045818
57,451 shares@ US$116.460.069% mcap30.9% of flowCommon StockSEC144:0001628280-26-045807
67,329 shares@ US$99.870.069% mcap31.1% of flowCommon StockSEC144:0001628280-26-045610
5,019 shares@ US$20.330.0021% mcap0.6% of flowCommonSEC144:0001628280-26-045612
16,542 shares@ US$98.250.017% mcap7.5% of flowCommon StockSEC144:0001628280-26-045289
19,973 shares@ US$20.260.0083% mcap2.4% of flowCommonSEC144:0001628280-26-045294
173 shares@ US$99.450.0002% mcap0.1% of flowCommon StockSEC144:0001628280-26-044985
30,774 shares@ US$20.870.013% mcap3.8% of flowCommonSEC144:0001628280-26-044988
34,152 shares@ US$90.430.031% mcap14.2% of flowCommon StockSEC144:0001628280-26-044732
14,128 shares@ US$89.900.013% mcap5.8% of flowCommon StockSEC144:0001628280-26-044426
12,902 shares@ US$87.440.011% mcap5.1% of flowCommon StockSEC144:0001628280-26-044012
22 of 22 declarations
